NF2 and breast cancer: Thus, in order to examine the effect of Merlin deficiency in modulating the cellular redox profile, we assessed a panel of human oxidative stress‐associated genes by a quantitative PCR array comparing NF2‐silenced breast cancer cells MCF7 (MCF7 KD), T47D (T47D KD), and MEF Nf2−/− to their respective non‐target control transfectants MCF7 (MCF7 NT) (Fig. S1C), T47D (T47D NT) (Fig. S1D), and MEF Nf2fl/fl (Fig. S1E).